Adesão terapêutica de pacientes infantis vivendo com HIV que utilizam tratamento antirretroviral: uma revisão.

Abstract

HIV is a retrovirus of the Lentiviridae family and known to be the causative agent of AIDS. If there were 35 million people living with the disease in the world, of these, about 3.3 million children are children. In Brazil, this number reaches 842,710 thousand people, of these 14,044,593 thousand are children 0-5 years old. The objective of this study is to investigate the factors that contribute to the therapeutic adherence of antiretroviral drugs in children aged 0 to 10 years. A literature review was carried out systematically in the main databases Scielo, Lilacs, Medline, Pubmed, Virtual Health Library and also National Health Committees, using articles published in the years 2006 to 2017, the research includes booklets and Protocols available from the ministry of health and UNAIDS. Therapeutic adherence to the use of antiretrovirals for children is a great challenge for caregivers and health professionals, since the prejudice around the disease still hinders the success of the treatment. The main complaint among children using ART is the pharmaceutical form of TARV, which often favors non-adherence to treatment. On the other hand, the commitment of health professionals and caregivers, together with the benefit and longevity that the use of TART brings to the children living with the disease, are determining factors for the success of the therapy.